RT Journal Article
SR Electronic
T1 Age classes stratified by risk and adaptive behavior during epidemics
JF medRxiv
FD Cold Spring Harbor Laboratory Press
SP 2023.05.30.23290737
DO 10.1101/2023.05.30.23290737
A1 Ronan F. Arthur
A1 May Levin
A1 Alexandre Labrogere
A1 Marcus W. Feldman
YR 2023
UL http://medrxiv.org/content/early/2023/06/05/2023.05.30.23290737.abstract
AB Heterogeneity in contact patterns, mortality rates, and transmissibility among and between different age classes can have significant effects on epidemic outcomes. Adaptive behavior in response to the spread of an infectious pathogen may give rise to complex epidemiological dynamics. Here we model an infectious disease in which adaptive behavior incentives, and mortality rates, can vary between three age classes. The model indicates that age-dependent variability in infection aversion can produce more complex epidemic dynamics at lower levels of pathogen transmissibility.Competing Interest StatementThe authors have declared no competing interest.Funding StatementThis study was partially funded by the John Templeton Foundation and by the Morrison Institute for Population and Resource StudiesAuthor DeclarationsI confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.YesI confirm that all necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived, and that any patient/participant/sample identifiers included were not known to anyone (e.g., hospital staff, patients or participants themselves) outside the research group so cannot be used to identify individuals.YesI understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).YesI have followed all appropriate research reporting guidelines, such as any relevant EQUATOR Network research reporting checklist(s) and other pertinent material, if applicable.YesAll data produced in the present work are contained in the manuscript.